Rashidul Haque and Sultana Rajia. AMP-kinase is the Main Target of Metformin in Regulating Type 2 Diabetes. RHDHR-V2 [Internet]. 2023 Feb. 14 [cited 2026 Jun. 4];:83-95. Available from: https://stm.bookpi.org/RHDHR-V2/article/view/9617